412: ECHO ABNORMALITIES IN CRITICALLY ILL STEM CELL TRANSPLANT RECIPIENTS. Crit Care Med. 2015;43(12 Suppl 1):104-105..
Eculizumab precision dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT. Blood Adv. 2022..
Improving the Timeliness of Chemotherapy Administration in the Bone Marrow Transplant Unit. Biol Blood Marrow Transplant. 2019..
Interferon-complement loop in transplant-associated thrombotic microangiopathy. Blood Adv. 2020;4(6):1166-1177..
The natural history of BK polyomavirus and the host immune response after stem cell transplantation. Clin Infect Dis. 2019.
A Prospective Study of Alemtuzumab as a Second Line Agent for Steroid Refractory Acute Graft Versus Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2016.
A reduced intensity conditioning regimen for patients with Dyskeratosis Congenita undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016..
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. Leuk Res. 2018.
Terminal complement blockade after HSCT is safe without meningococcal vaccination. Biol Blood Marrow Transplant. 2016..
Ultra-high dose vitamin D in pediatric hematopoietic stem cell transplantation: A nonrandomized controlled trial. Transplant Cell Ther. 2021.
Vitamin D Deficiency and Survival in Children after Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2015.